Salt Lake City, UT.
J Athl Train. 1999 Apr;34(2):144-9.
To determine whether women experience significantly greater anterior cruciate ligament (ACL) laxity in conjunction with estrogen and progesterone surges during a normal 28- to 30-day menstrual cycle.
Serial estrogen and progesterone levels were measured via radioimmunoassay procedures to identify the follicular and luteal phases of a subject's menstrual cycle and to determine periods of peak hormonal surges. Concomitant ACL laxity measures were taken using a knee arthrometer. Hormone levels and ACL laxity were assessed on days 1, 10, 11, 12, 13, 20, 21, 22, and 23 of the menstrual cycle. Day 1 corresponds to the menstrual phase, when estrogen and progesterone levels are at their lowest. Days 10 through 13 correspond to peak estrogen surge (follicular phase), and days 20 through 23 correspond to peak progesterone surge (luteal phase).
Seven active females between the ages of 21 and 32 years with at least one apparently healthy knee (no known knee anomalies) volunteered for participation in this study. Each subject stated that she experienced a normal (28- to 30-day) menstrual cycle and was not currently taking any type of hormone therapy (eg, birth control medication).
Blood was drawn on days 1, 10, 11, 12, 13, 20, 21, 22, and 23 of each subject's menstrual cycle, and ACL laxity measurements were assessed immediately after the blood draws. Estrogen and progesterone levels were determined via radioimmunoassay procedures, and ACL laxity was determined using a knee arthrometer.
A within-subjects, repeated-measures analysis of variance was applied to determine the presence or absence of significant differences in ACL laxity values over the course of a subject's menstrual cycle. We found a significant difference in ACL laxity when comparing baseline levels of estrogen with peak levels of estrogen. A significant increase in ACL laxity was also noted when comparing baseline levels of progesterone with peak levels of progesterone.
ACL laxity increased significantly throughout the menstrual cycle when comparing baseline with peak levels of estrogen and progesterone.
确定女性在正常的 28-30 天月经周期中是否会因雌激素和孕激素的激增而导致前交叉韧带(ACL)松弛度显著增加。
通过放射免疫测定程序测量连续的雌激素和孕激素水平,以确定受试者月经周期的卵泡期和黄体期,并确定激素激增的时期。同时使用膝关节测角仪测量 ACL 松弛度。在月经周期的第 1、10、11、12、13、20、21、22 和 23 天测量激素水平和 ACL 松弛度。第 1 天对应于月经阶段,此时雌激素和孕激素水平最低。第 10 天至第 13 天对应于雌激素激增峰值(卵泡期),第 20 天至第 23 天对应于孕激素激增峰值(黄体期)。
7 名年龄在 21 至 32 岁之间的活跃女性志愿者,她们至少有一个明显健康的膝盖(没有已知的膝盖异常)参加了这项研究。每位受试者都表示她经历了正常的(28-30 天)月经周期,并且目前没有服用任何类型的激素治疗(例如,避孕药)。
在每个受试者月经周期的第 1、10、11、12、13、20、21、22 和 23 天抽取血液,并在血液抽取后立即评估 ACL 松弛度。通过放射免疫测定程序确定雌激素和孕激素水平,并使用膝关节测角仪确定 ACL 松弛度。
应用受试者内重复测量方差分析来确定 ACL 松弛度值在受试者月经周期过程中是否存在显著差异。我们发现,在比较基线雌激素水平与雌激素峰值水平时,ACL 松弛度存在显著差异。在比较基线孕激素水平与孕激素峰值水平时,ACL 松弛度也显著增加。
当比较基线水平与雌激素和孕激素的峰值水平时,ACL 松弛度在整个月经周期中显著增加。